Source: KeAi From: news-medical.net Among the 7.8 million women with breast cancer worldwide, at least 33% to 44% are affected by lymphatic pain. Breast cancer survivors usually suffer lymphatic pain in the ipsilateral body or upper limb, and pharmacological approaches are not effective for lymphatic pain. In a recent publication (doi: https://doi.org/10.1016/j.wcn.2024.04.001) in Women and Children Nursing, a group of …
Nipple-Sparing Mastectomy: A Modern Approach to Breast Cancer Surgery
By: Rutgers Cancer Institute From: newswise.com Thanks to advances in breast cancer research and personalized treatment approaches, patients diagnosed with breast cancer now have more surgical options than ever before. Among these innovative approaches is the Nipple-Sparing Mastectomy (NSM)—a procedure that not only removes the cancerous tissue but also preserves the nipple and much of the breast’s natural appearance. Nipple-Sparing …
FDA Approves Inavolisib Plus Palbociclib/Fulvestrant for Endocrine-Resistant, PIK3CA-Mutated, HR+, HER2– Advanced Breast Cancer
By: Chris Ryan From: onclive.com Key Takeaways Inavolisib, combined with palbociclib and fulvestrant, is approved for specific breast cancer patients with PIK3CA mutations. The INAVO120 trial showed a median progression-free survival of 15.0 months for the inavolisib group versus 7.3 months for the placebo group. The FDA has approved inavolisib (Itovebi) in combination with palbociclib (Ibrance) and fulvestrant (Faslodex) for …
Study finds common breast cancer treatments may speed aging process
From: uclahealth.org A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has revealed that common breast cancer treatments, including chemotherapy, radiation, and surgery, may accelerate the biological aging process in breast cancer survivors. The findings, published in the Journal of the National Cancer Institute, show that markers of cellular aging—such as DNA damage response, cellular …
DAPK3 emerges as a new regulator of migration of triple-negative breast cancer cells
By: Ana María Rodríguez, Baylor College of Medicine From: medicalxpress.com Triple-negative breast cancer (TNBC) is the subtype of breast cancer that is the hardest to treat. TNBC patients account for more than 20,000 cases of this condition annually in the U.S. alone. They experience worse outcomes than patients with other breast cancer subtypes—their five-year mortality rate is about 40%. The …
Hormonal Contraception Linked to Increased Breast Cancer Risk in BRCA1 Carriers
By: Charles Bankhead, Senior Editor From: medpagetoday.com Carriers of the BRCA1 cancer gene had a significantly increased risk of breast cancer if they used hormonal contraception (HC), pooled cohort data showed. Breast cancer risk increased by 29% in BRCA1 carriers who reported any use of HC during at least one 12-month continuous period. The risk also increased with duration of …
Breast cancer awareness: It’s more than just pink
By: Courtney Franchio, Program Manager, VA National Oncology Program From: va.gov VA breast cancer resources and services At VA, breast cancer awareness is more than wearing pink ribbons. It’s about empowering individuals, especially Veterans and their caregivers, with the knowledge and resources to take charge of their health, know their risk factors and support those facing the diagnosis from treatment …
Beyond the Pink Ribbon: A Closer Look at Breast Cancer Progress
By: Sabrina Serani From: targetedonc.com Breast cancer remains a significant health challenge worldwide. Despite advancements in treatment, many women continue to face its devastating impact. In an interview with Targeted OncologyTM, Oranus Mohammadi, MD, medical oncologist at The Oncology Institute of Hope & Innovation, discussed the remarkable progress made in improving survival rates for patients with breast cancer. She delved …
AI Detects Breast Cancer Years Before Its Diagnosis
From: insideprecisionmedicine.com Commercially available artificial intelligence (AI) algorithms that help radiologists immediately detect breast cancer at mammography screening can also highlight women who are at risk years before their eventual diagnosis, research indicates. The findings, reported in JAMA Network Open, could offer a pathway for personalized screening that may lead to the earlier diagnosis of breast cancer. Mean absolute AI …
Breast Cancer Incidence Still Rises and Death Rate Still Declines
By: Carrie Printz and Sandy McDowell From: cancer.org A new American Cancer Society (ACS) report finds that the incidence of breast cancer in women has continued to increase, rising by 1% a year during 2012 to 2021, for all women combined. These cases are largely confined to localized-stage cancers, which have not spread from the breast, and hormone receptor-positive disease …